Trump's stock broker activity in Q1

Key Facts and Events: In Q1 2026, President Trump engaged in extensive stock trading, with notable activity in tech (Nvidia, Microsoft, Amazon, Meta), healthcare (Eli Lilly), and defense (Axon). He made 94 trades of 'Magnificent Seven' stocks, totaling over $50M, and executed hundreds of health care trades. Republican lawmakers also increased investments in Trump-touted stocks like Intel and bitcoin. Trump's trading sparked criticism from Sen. Elizabeth Warren, and media attention, including Jim Cramer's reaction on live TV.

Market Impact: Trump's trading activity influenced specific stocks and sectors. His purchases drove up demand for certain tech and healthcare stocks, while sales may have put downward pressure on others. The Axon purchase coincided with a government contract notice, raising potential conflicts of interest. GOP lawmakers' increased investments in Trump-favored stocks could signal sectoral trends, influencing market sentiment and valuation.

What to Watch Next: Trump's next financial disclosure, due in late July, will reveal his Q2 trading activity. This will provide insights into his evolving investment strategy and potential market impacts. Additionally, the U.S. Office of Government Ethics' review of Trump's trading activity, following Warren's criticism, may introduce regulatory or ethical considerations. Lastly, earnings reports from Trump-traded companies, such as Nvidia (Aug 17) and Microsoft (Oct 25), will offer updates on their financial health and market positioning.